Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies
Crossref DOI link: https://doi.org/10.1007/s40264-015-0374-9
Published Online: 2015-12-29
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dunne, Michael W.
Talbot, George H.
Boucher, Helen W.
Wilcox, Mark
Puttagunta, Sailaja
Funding for this research was provided by:
Durata Therapeutics, Inc
License valid from 2015-12-29